Doxazosin Tablet
Product Images NDC 71335-3081

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71335-3081). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 1)

Structure (Image 1)
Chemical structure diagram of doxazosin mesylate, showing its molecular arrangement with various rings, nitrogen atoms, and a methanesulfonate (mesylate) group.*
FDA Label Image

Image (Image 2)

Image (Image 2)
A data table with bar chart depicting the effects of Doxazosin Mesylate on symptom score and maximum flow rate across three studies. It compares placebo and varying Doxazosin doses, showing baseline means and mean changes in symptom scores and urine flow rates. Statistical significance is noted alongside the data.*
FDA Label Image

1 (Image 3)

1 (Image 3)
Two line graphs displaying clinical data for Doxazosin Mesylate tablets versus placebo over 14 weeks. The top graph shows mean change in total symptom score from baseline, with Doxazosin Mesylate group showing greater symptom reduction than placebo. The bottom graph illustrates mean increase in maximum urinary flow rate (mL/sec) from baseline, with the Doxazosin group showing higher flow rate improvement compared to placebo. Both graphs include error bars and statistical significance markers.*
FDA Label Image

Label (Lbl713353081)

Label (Lbl713353081)
Doxazosin Tablets USP 2 mg oral tablets label showing packaging details. The label states each tablet contains 2 mg Doxazosin Mesylate equivalent. It includes storage instructions, a QR code for dosage information, and indicates repackaging by Bryant Ranch Prepack and manufacturing by Piramal Pharma Limited. Package contains 30 tablets with NDC 71335-3081-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.